- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (31/01/2004)
- Gwreiddiol (a wnaed Fel)
Version Superseded: 18/05/2004
Point in time view as at 31/01/2004.
There are currently no known outstanding effects for the The Prescription Only Medicines (Human Use) Order 1997, SCHEDULE 3A.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Article 3A
Textual Amendments
F1Sch. 3A inserted (1.4.2002) by The Prescription Only Medicines (Human Use) Amendment Order 2002 (S.I. 2002/549), arts. 1(1), 9
Column 1 | Column 2 |
---|---|
Substance | Requirements as to use, route of administration, or pharmaceutical form |
Aciclovir | External use |
Acrivastine | Oral |
Adapalene | External use |
Alclometasone dipropionate | External use |
Alimemazine tartrate (trimeprazine tartrate) | Oral |
[F2Amitriptyline hydrochloride | Oral] |
Amorolfine hydrochloride | External use |
Amoxycillin trihydrate | Oral |
Aspirin | Oral |
Azelaic acid | External use |
Azelastine hydrochloride | Ophthalmic use or nasal |
[F2Azithromycin dihydrate | Oral] |
Baclofen | Oral administration in palliative care |
Beclometasone dipropionate | External use or nasal |
Betamethasone dipropionate | External use |
Betamethasone sodium phosphate | Aural or nasal |
Betamethasone valerate | External use |
Budesonide | Nasal |
[F2Carbamazepine | Oral or rectal] |
Carbaryl | External use |
Carbenoxolone sodium | Mouthwash |
Cetirizine hydrochloride | Oral |
Chloramphenicol | Ophthalmic use |
Cimetidine | Oral |
Cinchocaine hydrochloride | External use |
[F2Clavulanic acid | Oral] |
Clindamycin phosphate | External use |
Clobetasone butyrate | External use |
Clotrimazole | External use |
[F3Codeine Phosphate | Oral] |
[F2Conjugated oestrogens (equine) | External use] |
[F3Co-Phenotrope | Oral] |
Cyclizine | Parenteral administration in palliative care |
Dantrolene sodium | Oral administration in palliative care |
Dantron | Oral |
Desogestrel | Oral |
Desoximetasone (Desoxymethasone) | External use |
Dexamethasone | Aural |
Dexamethasone isonicotinate | Nasal |
[F3Diazepam | Oral, parenteral or rectal administration in palliative care] |
Diclofenac diethylammonium | External use |
[F2Diclofenac potassium | Oral] |
[F2Diclofenac sodium | Oral or rectal] |
[F3Dihydrocodeine Tartrate | Oral] |
Domperidone | Oral or rectal administration in palliative care |
Domperidone maleate | Oral administration in palliative care |
Doxycycline [F4hyclate] | Oral |
[F5Doxycycline monohydrate | Oral] |
Econazole nitrate | External use |
[F5Emedastine | Ophthalmic use] |
Erythromycin | External use [F6or oral] |
[F2Erythromycin ethyl succinate | Oral] |
[F2Erythromycin stearate | Oral] |
[F2Estradiol | External use] |
[F2Estriol | External use] |
Ethinylestradiol | Oral |
[F2Etonogestrel | Implant] |
Etynodiol diacetate (ethynodiol diacetate) | Oral |
Famotidine | Oral |
Felbinac | External use |
Fenticonazole nitrate | External use |
Fexofenadine hydrochloride | Oral |
[F5Flucloxacillin magnesium | Oral] |
Flucloxacillin sodium | Oral |
Fluconazole | Oral |
Fludroxycortide (Flurandrenolone) | External use |
[F2Flumazenil | Parenteral] |
Flumetasone pivalate | Aural |
Flunisolide | Nasal |
Fluocinolone acetonide | External use |
Fluocinonide | External use |
Fluocortolone hexanoate | External use |
Fluocortolone pivalate | External use |
Flurbiprofen | Lozenges |
Fluticasone propionate | External use or nasal |
Fusidic acid | [F7External Use] |
[F2Gabapentin | Oral] |
Gentamicin sulphate | Aural |
Gestodene | Oral |
[F2Glucagon hydrochloride | Parenteral] |
[F2Glucose | Parenteral] |
Hydrocortisone | External use |
Hydrocortisone acetate | External use |
Hydrocortisone butyrate | External use |
Hydrocortisone sodium succinate | Lozenges |
Hyoscine butylbromide | Parenteral [F8or transdermal] administration in palliative care |
Hyoscine hydrobromide | [F9Oral or parenteral administration in palliative care] |
Ibuprofen | External use or oral |
Ibuprofen lysine | Oral |
[F2Imipramine hydrochloride | Oral] |
Ipratropium bromide | Nasal |
Isotretinoin | External use |
Ketoconazole | External use |
Ketoprofen | External use |
Levocabastine hydrochloride | Ophthalmic use or nasal |
Levomepromazine (methotrimeprazine) maleate | Oral administration in palliative care |
Levomepromazine (methotrimeprazine) hydrochloride | Parenteral administration in palliative care |
Levonorgestrel | Oral |
[F2Lignocaine hydrochloride | External use or parenteral] |
Lithium succinate | External use |
Lodoxamide trometamol | Ophthalmic use |
Loperamide hydrochloride | Oral |
Loratadine | Oral |
[F3Lorazepam | Oral or parenteral administration in palliative care] |
[F2Lymecycline | Oral] |
Mebendazole | Oral |
Medroxyprogesterone acetate | Parenteral |
Mestranol | Oral |
Metoclopramide hydrochloride | Oral or parenteral administration in palliative care |
Metronidazole | [F10External use, oral or rectal] |
Metronidazole benzoate | Oral |
Miconazole | Dental lacquer |
Miconazole nitrate | External use |
[F3Midazolam | Parenteral administration in palliative care] |
Minocycline | Oral |
[F5Mizolastine | Oral] |
[F5Minocycline hydrochloride | Oral] |
Mometasone furoate | External use or nasal |
Nedocromil sodium | Ophthalmic use |
Nefopam hydrochloride | Oral |
Neomycin sulphate | Aural |
Neomycin undecenoate | Aural |
Nitrofurantoin | Oral |
Nizatidine | Oral |
Norethisterone 9 | Oral |
Norethisterone acetate | Oral |
Norethisterone enanthate | Parenteral |
Norgestimate | Oral |
Norgestrel | Oral |
[F2Nortriptyline hydrochloride | Oral] |
Nystatin | External use |
Oxytetracycline dihydrate | Oral |
Paracetamol | Oral |
Penciclovir | External use |
Piroxicam | External use |
[F2Prednisolone | Oral] |
Prednisolone hexanoate | External use |
Prednisolone sodium phosphate | Aural [F11or oral] |
Ranitidine hydrochloride | Oral |
[F2Salbutamol sulphate | Inhalation] |
Silver sulphadiazine | External use |
Sodium cromoglycate | Ophthalmic use |
[F2Sodium fusidate | External use] |
Streptodornase | External use |
Streptokinase | External use |
Sulconazole nitrate | External use |
Terbinafine hydrochloride | External use |
[F2Terbutaline sulphate | Inhalation] |
Tetracycline hydrochloride | External use or oral |
Tretinoin | External use |
Triamcinolone acetonide | External use, aural, nasal or oral paste |
Trimethoprim | Oral |
Tuberculin PPD | Parenteral |
Vaccine, Adsorbed Diphtheria | Parenteral |
Vaccine, Adsorbed Diphtheria And Tetanus | Parenteral |
Vaccine, Adsorbed Diphtheria And Tetanus For Adults And Adolescents | Parenteral |
Vaccine, Adsorbed Diphtheria For Adults And Adolescents | Parenteral |
Vaccine, Adsorbed Diphtheria, Tetanus And Pertussis | Parenteral |
Vaccine, Adsorbed Diphtheria, Tetanus And Pertussis (Acellular Component) | Parenteral |
Vaccine, BCG | Parenteral |
Vaccine, BCG Percutaneous | Parenteral |
Vaccine, Haemophilus Influenzae Type B (Hib) | Parenteral |
Vaccine, Haemophilus Influenzae Type B (Hib) with Diphtheria, Tetanus And Pertussis | Parenteral |
Vaccine, Haemophilus Influenzae Type B, Diphtheria, Tetanus And Acellular Pertussis | Parenteral |
Vaccine, Hepatitis A | Parenteral |
Vaccine, Hepatitis A With Typhoid | Parenteral |
Vaccine, Hepatitis A, Inactivated, With Recombinant (DNA) Hepatitis B | Parenteral |
Vaccine, Hepatitis B | Parenteral |
Vaccine, Influenza | Parenteral |
Vaccine, Live Measles, Mumps And Rubella (MMR) | Parenteral |
Vaccine, Meningococcal Group C Conjugate | Parenteral |
Vaccine, Meningococcal Polysaccharide A and C | Parenteral |
Vaccine, Pneumococcal | Parenteral |
F12. . . | F12. . . |
Vaccine, Poliomyelitis, Live (Oral) | Oral |
Vaccine, Rubella, Live | Parenteral |
Vaccine, Tetanus, Adsorbed | Parenteral |
Vaccine, Typhoid, Live Attenuated (Oral) | Oral |
Vaccine, Typhoid, Polysaccharide | Parenteral |
[F5Water for Injections | Parenteral]] |
Textual Amendments
F2Sch. 3A entries inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(g)
F3Words in Sch. 3A inserted (10.12.2003) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2003 (S.I. 2003/2915), arts. 1(1), 3
F4Words in Sch. 3A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(a)
F5Words in Sch. 3A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(c)
F6Words in Sch. 3A inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(a)
F7Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(b)
F8Words in Sch. 3A inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(c)
F9Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(d)
F10Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(e)
F11Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(f)
F12Words in Sch. 3A omitted (4.4.2003) by virtue of The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(b)
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys